BridgeBio Pharma (BBIO) free cash flow

Free cash flow · fiscal 2025
-$455.50M

BridgeBio Pharma (BBIO) generated free cash flow of -$455.50M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$529.63M. Figures as of 18 Nov 2026, 12:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$455.50M
Highest on record
-$40.95Mfiscal 2017
Lowest on record
-$529.63Mfiscal 2024
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BridgeBio Pharma free cash flow, in more detail

Across the 9 fiscal years on record (2017–2025), the highest was -$40.95M in fiscal 2017 and the lowest -$529.63M in fiscal 2024.

History · 9 fiscal years

Free cash flow by fiscal year

BridgeBio Pharma free cash flow, year by year

BridgeBio Pharma (BBIO) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$455.50M—
2024-$529.63M—
2023-$529.03M—
2022-$425.82M—
2021-$511.18M—
2020-$407.23M—
2019-$256.23M—
2018-$138.82M—
2017-$40.95M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of BridgeBio Pharma and comparable companies
CompanyFree cash flowFiscal year
ICON ICLR$861.99M2025
Jazz Pharmaceuticals JAZZ$1.15B2025
BridgeBio Pharma BBIO-$455.50M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BBIO

BridgeBio Pharma, figure by figure

BridgeBio Pharma (BBIO) overview: price, valuation and scorecardAll health care companies by market value

BridgeBio Pharma free cash flow: questions and answers

What is BridgeBio Pharma's free cash flow?

BridgeBio Pharma (BBIO) generated free cash flow of -$455.50M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$529.63M.

What are the highest and lowest free cash flow figures on record for BridgeBio Pharma?

Across the 9 fiscal years on record (2017–2025), the highest was -$40.95M in fiscal 2017 and the lowest -$529.63M in fiscal 2024.

How is BridgeBio Pharma's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For BridgeBio Pharma it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BridgeBio Pharma (BBIO) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BBIO/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.